Oncology
2018-08-19 7.致德樓第六會議室 (Chih-De Rm 6)
時間主題
09:00 ~ 09:10
PD5-1: The effect of BAP1 and PBRM1 mutation on outcomes in patients with clear cell renal cell carcinoma (CCRCC)
講者: 戴盟哲 座長: 溫玉清,
侯鎮邦
09:10 ~ 09:20
PD5-2: Comparing the value of dap score and renal score for long-term outcomes in robot-assisted partial nephrectomy for renal cell carcinoma patients
講者: 連繼志 座長: 溫玉清,
侯鎮邦
09:20 ~ 09:30
PD5-3: Survival benefit after cytoreductive nephrectomy in metastatic renal cell carcinoma: CGMH-LK experience in targeted therapy era
講者: 李承哲 座長: 溫玉清,
侯鎮邦
09:30 ~ 09:40
PD5-4: To investigate the duration of initial diagnosis of urothelial cell carcinoma and renal tumor in Taiwan patients with dialysis – a nationwide population-based cohort study
講者: 高建璋 座長: 溫玉清,
侯鎮邦
09:40 ~ 09:50
PD5-5: Outcome of patients with T1 renal cell carcinoma received partial nephrectomy: VGHTC experience
講者: 張瓈文 座長: 溫玉清,
侯鎮邦
09:50 ~ 10:00
PD5-6: Modified hand-assisted retroperitoneoscopic nephroureterectomy with an adjunctive port for the treatment of upper urinary tract tumor
講者: 陳義昇 座長: 溫玉清,
侯鎮邦